Optimizing Survival in Advanced Prostate Cancer: Conclusion
Optimizing Survival in Advanced Prostate Cancer: Conclusion
ecancermedicalscience editor's choice for December 2014
UICC 2014 conference report
Combination of eribulin and capecitabine provides clinical benefit for women with metastatic breast cancer
High tumour immune cell levels may help screen HER2-positive breast cancer patients for chemo
CLL at ASH 2014: Expert discussion
Comment: Combining tamoxifen with ovarian suppression reduced recurrence of some breast cancers
BOLERO-1 reports HER2-positive breast cancer latest PFS data
Impact of adding bevacizumab to presurgery chemo for triple-negative breast cancer varies with subtype
Progression-free survival results from BOLERO-1 trial
Ovarian suppression with tamoxifen reduced recurrence in some premenopausal breast cancer cases
Comment: Capecitabine for elderly early-stage breast cancer